Loading…
Specialty chemicals/pyridine-chemistry maker (demerged from Jubilant Life Sciences) supplying agrochemical and nutrition ingredients.
Specialty chemicals/pyridine-chemistry maker (demerged from Jubilant Life Sciences) supplying agrochemical and nutrition ingredients.
Makes pyridine-based chemicals sold into agrochemical, nutrition and pharma uses, so profit depends on the price gap against Chinese and European competitors. It was split off from Jubilant Life Sciences in 2021 and belongs to the Jubilant Bhartia group.
Moat: narrow (scale, process know-how). One of the world's largest pyridine-chemistry producers, but Chinese and European rivals compete on price.
Headquarters: Noida, India · Founded: 2020 · Employees: 3,429
Size Jubilant Ingrevia (JUBLINGREA.NS) is an India Materials company (Chemicals: Major Diversified) with a market value of $966M, the 606th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹572.40 on 6 Nov 2026.
Performance Over six months the shares fell 24.4%, against -27.4% for the median peer and 0.0% for the India market (cap-weighted) — 10th highest of 21 in its peer set.
Growth Revenue grew 15.4% over the last twelve months (peer median +1.2%); the operating margin is 10.3% (peer median 16.1%).
Valuation It trades at 21.1× forward earnings against a peer median of 21.7× (8th cheapest of 16).
Price implies For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +45%, so the hurdle is -18 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.9 points below its cost of capital (15.3% WACC).
Next results Next results expected around 2 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹49.2B | ₹43.6B | ₹41.6B | ₹41.2B | ₹47.7B |
| Revenue growth | — | +5% | +1% | -14% | — |
| Gross profit | ₹12.8B | ₹8.08B | ₹7.63B | ₹6.90B | ₹7.62B |
| EBITDA | ₹7.01B | ₹5.74B | ₹5.24B | ₹4.36B | ₹5.67B |
| Net income | ₹3.51B | ₹2.78B | ₹2.51B | ₹1.83B | ₹3.07B |
| Free cash flow | n/a | ₹1.63B | ₹729M | -₹2.05B | -₹618M |
| Capital expenditure | n/a | ₹2.99B | ₹3.66B | ₹5.68B | ₹4.81B |
| Total debt | ₹8.95B | ₹7.92B | ₹7.64B | ₹7.40B | ₹4.07B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Jubilant Ingrevia JUBLINGREA.NS | $966M | -24% | +15% | 10% | 21.1× | 27.3% |
| Lonza LONN.SW | $55.4B | +39% | -11% | 25% | 36.1× | 15.0% |
| DSM-Firmenich DSFIR.AS | $29.5B | +62% | -45% | 8% | 30.1× | 24.3% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | JUBLINGREA.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -10.9% | -14.1% | 10th highest of 21 |
| 6-month return | -24.4% | -27.4% | 10th highest of 21 |
| Distance from 52-week high | -28.0% | -46.2% | 7th highest of 21 |
| Revenue growth (TTM) | +15.4% | +1.2% | 3rd highest of 21 |
| Operating margin | 10.3% | 16.1% | 8th lowest of 21 |
| Forward P/E | 21.1× | 21.7× | 8th cheapest of 16 |
| Growth the price implies (Req g, 7 yrs) | 27.3% | 9.1% | 5th most demanding of 15 |
| Growth delivered (Del g) | +44.9% | +6.6% | highest of 15 |
| Hurdle (Req g minus delivered) | -17.6 pp | +0.5 pp | 3rd least demanding of 15 |
| ROIC minus cost of capital | -5.9 pp | -0.7 pp | 4th lowest of 21 |
| EV / EBITDA | 14.0× | 12.0× | 5th most expensive of 10 |
| Net debt / EBITDA | 1.0× | -1.5× | 2nd most indebted of 11 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Jubilant Ingrevia JUBLINGREA.NS | India | $966M | -24% | +15% | 10% | 21.1× | 27.3% | +44.9% |
| Jiangsu Zhengdan Chemical Industry 300641.SZ | China | $981M | -28% | -30% | 17% | n/a | 8.8% | +11.6% |
| Zhejiang Huangma Technology 603181.SS | China | $935M | -30% | +7% | 17% | 14.5× | n/a | n/a |
| Caregen 214370.KS | South Korea | $1.01B | -73% | -8% | 24% | 22.6× | 35.2% | +3.8% |
| Victrex VCT.L | United Kingdom | $1.04B | +54% | -1% | 14% | 21.7× | 15.7% | +1.9% |
| Dalian Bio-Chem 603360.SS | China | $1.05B | -55% | 0% | 16% | 23.5× | 9.5% | +18.4% |
| Guangzhou Sanfu Newmaterials Technology 688359.SS | China | $870M | -41% | +8% | -7% | n/a | n/a | n/a |
| Suzhou Highfine Biotech 301393.SZ | China | $865M | -8% | +36% | 17% | 32.3× | n/a | n/a |
| Raghav Productivity Enhancers RPEL.NS | India | $864M | +133% | +38% | 28% | n/a | n/a | n/a |
| Polyrocks Chemical 688669.SS | China | $831M | +40% | -8% | -6% | n/a | 35.9% | +15.2% |
| Sanyo Chemical Industries 4471.T | Japan | $823M | +24% | 0% | 10% | 10.5× | -5.1% | -2.5% |
| Jiangxi Hungpai New Material 605366.SS | China | $821M | -47% | +2% | -11% | 236.0× | n/a | n/a |
| Xinyaqiang Silicon Chemistry 603155.SS | China | $788M | -6% | +6% | 10% | 37.0× | 31.1% | +3.9% |
| Nippon Soda 4041.T | Japan | $1.19B | -5% | -1% | 10% | 11.1× | 3.5% | +1.8% |
| Hubei Jianghan New Materials 603281.SS | China | $1.20B | -30% | +8% | 17% | 20.5× | 4.8% | +6.3% |
| Hubei Chaozhuo Aviation Technology 688237.SS | China | $776M | +6% | -1% | 1% | 41.5× | 45.3% | +26.0% |
| CNSIG Inner Mongolia Chemical Industry 600328.SS | China | $1.21B | -32% | -20% | -7% | n/a | n/a | n/a |
| Daxin Materials 5234.TW | Taiwan | $767M | -42% | +10% | 19% | 25.7× | 17.7% | +1.5% |
| JCU 4975.T | Japan | $759M | -26% | +2% | 40% | 13.6× | 6.3% | +7.0% |
| Xinxiang Richful Lube Additive 300910.SZ | China | $1.26B | -38% | +12% | 16% | 11.6× | 0.6% | +32.5% |
| Jinan Acetate Chemical 4763.TW | Taiwan | $1.26B | -3% | -36% | 46% | 7.3× | -17.4% | +41.2% |